Name: UMIN ID:
Unique ID issued by UMIN | UMIN000015478 |
---|---|
Receipt number | R000017991 |
Scientific Title | A study on the efficacy and biogenic adaptability affected by ipragliflozin |
Date of disclosure of the study information | 2015/07/01 |
Last modified on | 2019/12/09 17:38:38 |
No. | Disposal | Last modified on | Item of update | |
---|---|---|---|---|
1 | Insert | 2014/10/20 13:36:38 | ||
2 | Update | 2014/11/25 09:28:43 | Date of disclosure of the study information |
|
3 | Update | 2015/01/22 16:46:16 | Date of disclosure of the study information |
|
4 | Update | 2015/03/26 09:15:29 | Date of disclosure of the study information |
|
5 | Update | 2015/04/21 09:17:12 | Date of disclosure of the study information |
|
6 | Update | 2015/04/21 09:19:51 | Anticipated trial start date |
|
7 | Update | 2015/05/25 16:44:14 | Date of disclosure of the study information |
|
8 | Update | 2015/06/18 09:38:07 | Narrative objectives1 Narrative objectives1 Primary outcomes Primary outcomes Key secondary outcomes Key secondary outcomes |
|
9 | Update | 2015/06/18 09:48:51 | Key inclusion criteria Key inclusion criteria Key exclusion criteria Key exclusion criteria |
|
10 | Update | 2015/06/18 09:56:09 | Address Address TEL Address Address TEL Organization Organization Organization1 Address1 Tel1 Email1 |
|
11 | Update | 2015/06/18 09:57:21 | Date of protocol fixation Anticipated trial start date |
|
12 | Update | 2015/06/26 13:28:54 | Key exclusion criteria Key exclusion criteria |
|
13 | Update | 2015/07/10 09:26:59 | Key secondary outcomes Key secondary outcomes |
|
14 | Update | 2015/07/10 09:33:26 | Key exclusion criteria Key exclusion criteria |
|
15 | Update | 2015/11/04 13:21:00 | Recruitment status Publication of results |
|
16 | Update | 2015/11/24 10:46:27 | Public title Public title Acronym Acronym |
|
17 | Update | 2016/10/04 09:38:27 | Address Last name of contact person Last name of contact person Organization Organization Division name Division name Address Address TEL Name of person sending information Name of primary person or sponsor Organization |
|
18 | Update | 2017/04/25 15:27:28 | Key exclusion criteria Key exclusion criteria |
|
19 | Update | 2017/04/25 15:28:20 | Organization Organization |
|
20 | Update | 2017/10/25 11:22:25 | Recruitment status |
|
21 | Update | 2019/04/19 15:49:38 | UMIN ID1 |
|
22 | Update | 2019/11/29 16:22:56 | 1st name of lead principal investigator Last name of lead principal investigator 1st name of lead principal investigator Last name of lead principal investigator Zip code Last name of contact person Last name of contact person Zip code Organization Organization Address Address Tel |
|
23 | Update | 2019/12/09 13:21:31 | Number of participants that the trial has enrolled |
|
24 | Update | 2019/12/09 13:23:30 | Date of IRB Anticipated trial start date Last follow-up date |
|
25 | Update | 2019/12/09 13:33:31 | URL releasing protocol URL related to results and publications Results Results Results date posted Baseline Characteristics Baseline Characteristics Participant flow Participant flow Adverse events Adverse events Outcome measures Outcome measures |
|
26 | Update | 2019/12/09 13:39:11 | Recruitment status |
|
27 | Update | 2019/12/09 17:38:38 | Publication of results |